The European and Mediterranean League against Thrombotic Diseases (EMLTD) is organized for scientific and educational purposes and has as its objectives and aims to promote the study of the origin and causes of thromboembolic diseases as well as their diagnosis, prophylaxis, and treatment and to gather professionals interested in thrombosis and Hemostasis from the basic to clinical sciences.
Since 1969 the EMLTD has organized a congress every 2 years and expanded its reach by including more countries and collaborating with societies involved in hemostasis and thrombosis. Link of the society: https://medleague-thrombosis.org/
The 27th ICT will take place virtually on November 26 and 27 2021 and will cover topics from COVID-19, Vaccines, and Thrombosis Risk, the Underlying Mechanisms and Management, Immunothrombosis, DOACs in pediatric medicine, Antithrombotics in patients with intracardiac devices, New Insights in Cancer-Associated Thrombosis, Obstetrics and Perimenopausal Thrombosis, Ischemic stroke prevention in patients with atrial fibrillation, to The challenges of bleeding in antithrombotic treatment.
Congress Link: https://ict2021.com/
Registration Link: https://ict2021.com/registration
Programme Link Day 1: https://ict2021.com/programme-26
Program Link Day 2: https://ict2021.com/programme-27
Timetable
November 26th: 9.00am to 12.30pm CET and 2.00pm to 6.00pm CET
November 27th: 9.00am to 12.30pm CET and 2.00pm to 5.00pm CET
Join us Virtually!
Hemostasis Marketing Team



